kabutan

D.Western Therapeutics Institute, Inc., January-September (Third Quarter Cumulative) Net Income Loss Widens, July-September Net Income Loss Widens

Thu Nov 14, 2024 3:30 pm JST Earnings

4576 D.Western Therapeutics Institute, Inc. 【J-GAAP】

Earnings Report

D.Western Therapeutics Institute, Inc. <4576> [TSE-G] announced its financial results after the market closed on November 14th (15:30). The consolidated net loss for the cumulative third quarter of the fiscal year ending December 2024 (January to September) expanded to a loss of 727 million yen (compared to a loss of 443 million yen in the same period last year).

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the October to December period (4Q) is expected to expand to a loss of 783 million yen (compared to a loss of 369 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated net loss expanded to a loss of 207 million yen (compared to a loss of 196 million yen in the same period last year). The operating profit/loss margin worsened from -157.9% in the same period last year to -158.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 309 -251 -239 -226 -7.7 ー Nov 10, 2022 J-GAAP
Jan - Sep, 2023 313 -457 -453 -443 -14.0 ー Nov 10, 2023 J-GAAP
Jan - Sep, 2024 348 -647 -665 -727 -21.6 ー Nov 14, 2024 J-GAAP
YoY +11.2% -41.6% -46.8% -64.1% -54.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 241 -540 -542 -565 -17.8 0 Feb 9, 2024 J-GAAP
Jul - Dec, 2024 Guidance 177 -1,051 -1,051 -990 -24.2 0 Aug 9, 2024 J-GAAP
YoY -26.6% -94.6% -93.9% -75.2% -36.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 448 -305 -295 -429 -14.5 0 Feb 13, 2023 J-GAAP
Dec, 2023 428 -798 -796 -812 -25.6 0 Feb 9, 2024 J-GAAP
Dec, 2024 Guidance 400 -1,500 -1,510 -1,510 -36.9 0 Feb 9, 2024 J-GAAP
YoY -6.5% -88.0% -89.7% -86.0% -44.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 126 -199 -199 -196 -6.2 -157.9 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 115 -341 -343 -369 -11.6 -296.5 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 104 -318 -320 -320 -10.0 -305.8 May 13, 2024 J-GAAP
Apr - Jun, 2024 119 -131 -139 -200 -6.2 -110.1 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 125 -198 -206 -207 -6.2 -158.4 Nov 14, 2024 J-GAAP
YoY -0.8% +0.5% -3.5% -5.6% +0.8%

Related Articles